Showing results (1421-1430 of 2,433) with videos related to

Sort By:
Pageof 244
Biomedicines|December 29, 2020
Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKDElena Dozio, Simone Vettoretti, Lara Caldiroli, et al.
Immunity & Ageing : I & A|June 21, 2017
Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational studyEmanuela Galliera, Monica Gioia Marazzi, Carmine Gazzaruso, et al.
Sensors (Basel, Switzerland)|January 23, 2020
Neutrons for Cultural Heritage-Techniques, Sensors, and DetectionGiulia Festa, Giovanni Romanelli, Roberto Senesi, et al.
Aging Clinical and Experimental Research|February 10, 2021
Development and validation of a delirium risk assessment tool in older patients admitted to the Emergency Department Observation UnitA Zucchelli, R Apuzzo, C Paolillo, et al.
Molecules (Basel, Switzerland)|August 12, 2022
Pro-Apoptotic and Pro-Autophagic Properties of Cardenolides from Aerial Parts of Pergularia tomentosaStefania Martucciello, Gaetana Paolella, Antonio Massimiliano Romanelli, et al.
The International Journal of Lower Extremity Wounds|January 4, 2023
An Integrated Systemic and Local Wound Management in Recalcitrant Pyoderma GangrenosumGiorgia Salvia, Alessandra Michelucci, Giammarco Granieri, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Inhibition of P-glycoprotein-mediated Multidrug Resistance (MDR) by N,N-bis(cyclohexanol)amine aryl esters: further restriction of molecular flexibility maintains high potency and efficacyCecilia Martelli, Silvia Dei, Catherine Lambert, et al.
World Journal of Gastroenterology|March 30, 2006
Uveitis in autoimmune hepatitis: a case reportRoberto Giulio Romanelli, Giorgio La Villa, Fabio Almerigogna, et al.
Archiv Der Pharmazie|February 1, 1996
Reduced flexibility analogs of analgesic and cognition enhancing alpha-tropanyl estersD Manetti, M N Romanelli, A Bartolini, et al.
Oncology Research|February 24, 2006
Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoterMonica Borgatti, Douglas D Boyd, Ilaria Lampronti, et al.
Pageof 244